| Historic (2004-11-01 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Tamiflu
|
11691 |
148667.3 |
  |
| 2 |
flu
|
6030 |
66778.0 |
  |
| 3 |
GlaxoSmithKline
|
1670 |
25616.1 |
  |
| 4 |
influenza
|
1331 |
18481.2 |
  |
| 5 |
CDC
|
1180 |
17364.6 |
  |
| 6 |
Glaxo
|
820 |
11958.1 |
  |
| 7 |
Roche
|
700 |
10988.8 |
  |
| 8 |
Biota
|
740 |
10432.2 |
  |
| 9 |
48 hours
|
490 |
8870.9 |
  |
| 10 |
Disease Control
|
390 |
6541.4 |
  |
| 11 |
H3
|
350 |
6353.3 |
  |
| 12 |
United States
|
481 |
6285.3 |
  |
| 13 |
H1
|
340 |
6182.2 |
  |
| 14 |
U.S.
|
450 |
5936.0 |
  |
| 15 |
Mexico
|
440 |
5884.3 |
  |
|
| 365 days (2008-06-04 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Tamiflu
|
5941 |
71887.5 |
  |
| 2 |
flu
|
3060 |
31537.4 |
  |
| 3 |
CDC
|
770 |
10647.6 |
  |
| 4 |
GlaxoSmithKline
|
670 |
9919.3 |
  |
| 5 |
Mexico
|
440 |
5319.7 |
  |
| 6 |
influenza
|
291 |
4026.4 |
  |
| 7 |
United States
|
301 |
3793.7 |
  |
| 8 |
U.S.
|
310 |
3739.3 |
  |
| 9 |
Anne Schuchat
|
210 |
3316.1 |
  |
| 10 |
Seiden Pharmaceutical Strategies
|
170 |
3192.6 |
  |
| 11 |
Carl Seiden
|
170 |
3074.7 |
  |
| 12 |
Roche
|
190 |
2977.9 |
  |
| 13 |
H1N1
|
220 |
2933.1 |
  |
| 14 |
48 hours
|
170 |
2895.7 |
  |
| 15 |
Roche Holding AG
|
120 |
2162.6 |
  |
|
| 30 days (2009-05-05 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Tamiflu
|
1620 |
17464.3 |
  |
| 2 |
flu
|
460 |
4627.6 |
  |
| 3 |
GlaxoSmithKline
|
270 |
3563.3 |
  |
| 4 |
CDC
|
260 |
3311.8 |
  |
| 5 |
Anne Schuchat
|
190 |
2572.0 |
  |
| 6 |
Mexico
|
210 |
2350.3 |
  |
| 7 |
U.S.
|
170 |
1675.4 |
  |
| 8 |
Roche
|
90 |
1240.8 |
  |
| 9 |
H1N1
|
110 |
1186.7 |
  |
| 10 |
Gilead Sciences Sciences
|
80 |
1148.6 |
  |
| 11 |
Australia
|
90 |
1010.0 |
  |
| 12 |
influenza
|
80 |
983.3 |
  |
| 13 |
48 hours
|
60 |
961.0 |
  |
| 14 |
United States
|
70 |
799.6 |
  |
| 15 |
neuraminidase
|
50 |
773.0 |
  |
|